A research team from Wayne State University recently published a paper in the Journal of Clinical Investigation that provides a paradigm shift in the understanding of cellular and molecular mechanisms underlying diabetic peripheral neuropathy (DPN) and wound healing in the treatment of corneal and
skin diabetic ulcers.
Not exact matches
A new high - tech but simple ointment applied to the
skin may one day help
diabetic patients heal stubborn and painful
ulcers on their feet, Northwestern University researchers report.
Dr Wenxin Wang is trying to uncover therapies for diseases such as
diabetic ulcers and Epidermolysis Bullosa, which causes chronic
skin conditions: «We are currently investigating the use of these new materials for biomedical applications such as drug / gene delivery, cross linkable hydrogel materials and
skin adhesives.
B cell treatment also quickly reduced the size and improved the healing of chronic
skin ulcers in the
diabetic mice, increasing the number of both nerve endings and blood vessels in regenerated tissue.
«Mature B lymphocytes accelerate the healing of
diabetic ulcers, other
skin injuries: Direct application of immune cells speeds and improves healing of acute and chronic wounds in animal models.»
One small study reported promising results with tissue - engineered products to promote healing of
diabetic skin ulcers.
For
diabetic ulcers, these were cadexomer iodine ointment, filgrastim, intensified treatment, staged management diabetes foot program, ertapenem, ampicillin / sulbactam,
skin replacement, promogran dressing, and becaplermin gel.
Performed direct care to surgical clients with
skin and skeletal traction, orthopedic surgeries, general abdominal surgeries, burns (1, 2, 3,),
diabetic ulcer foot.